Update on management and progress of novel therapeutics for R/R AML: an Iberian expert panel consensus

Overview of attention for article published in Annals of Hematology, October 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 26 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 9 publications that cite this research output.

9

The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.

Low-dose hypomethylating agents cooperate with ferroptosis inducers to enhance ferroptosis by regulating the DNA methylation-mediated MAGEA6-AMPK-SLC7A11-GPX4 signaling pathway in acute myeloid leukemia

Article in Experimental Hematology & Oncology (February 2024)

Novel Tools for Diagnosis and Monitoring of AML

Article in Current Oncology (May 2023)

Epigenetically silenced DACT3 promotes tumor growth via affecting Wnt/beta-catenin signaling and supports chidamide plus azacitidine therapy in acute myeloid leukemia

Preprint in bioRxiv (January 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.